The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-β (Aβ) 40, Aβ42, apolipoprotein E and transthyretin in human cerebrospinal fluid

Bretler, 1992, Epidemiology of Alzheimer disease, Epidemiol Rev, 14, 59, 10.1093/oxfordjournals.epirev.a036092 Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer’s disease, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8 Schmechel, 1993, Increased amyloid-β peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc Natl Acad Sci, 90, 9649, 10.1073/pnas.90.20.9649 Strittmatter, 1993, Apolipoprotein E, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 Tomlinson, 1968, Observations on the brains of non-demented old people, J Neurol Sci, 7, 331, 10.1016/0022-510X(68)90154-8 Mirra, 1991, The consortium to establish a registry for Alzheimer’s disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer’s disease, Neurol, 41, 479, 10.1212/WNL.41.4.479 Glenner, 1984, Alzheimer’s disease, Biochem Biophys Res Comm, 120, 885, 10.1016/S0006-291X(84)80190-4 Podlisny, 1990, Detection of soluble forms of the β-amyloid precursor protein in human plasma, Biochem Biophys Res Commun, 167, 1094, 10.1016/0006-291X(90)90635-Z Seubert, 1992, Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluid, Nature, 359, 325, 10.1038/359325a0 Palmert, 1989, The β-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid, Proc Natl Acad Sci USA, 86, 6338, 10.1073/pnas.86.16.6338 Berr, 1994, Apolipoprotein E allele ϵ4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer’s disease, Neurosci Lett, 178, 221, 10.1016/0304-3940(94)90763-3 Polvikoski, 1995, Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein, N Engl J Med, 333, 1242, 10.1056/NEJM199511093331902 Jarrett, 1993, The carboxyl terminus of the β amyloid protein is critical for the seeding of amyloid formation, Biochem, 32, 4693, 10.1021/bi00069a001 Citron, 1994, Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation, Proc Natl Acad Sci USA, 91, 11993, 10.1073/pnas.91.25.11993 Wisniewski, 1993, Apolipoprotein E, Biochem Biophys Res Commun, 192, 359, 10.1006/bbrc.1993.1423 Schwarzman, 1994, Transthyretin sequesters amyloid β protein and prevents amyloid formation, Proc Natl Acad Sci, 91, 8368, 10.1073/pnas.91.18.8368 Namba, 1991, Distribution of clusterin in Alzheimer brain tissue, Brain Res, 541, 163, 10.1016/0006-8993(91)91092-F Motter, 1995, Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease, Ann Neurol, 38, 643, 10.1002/ana.410380413 Blennow, 1994, Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer’s disease, Neuroreport, 5, 2534, 10.1097/00001756-199412000-00032 Hill, 1990, Improved phenotyping of apolipoprotein E, Clin Chem, 36, 1871, 10.1093/clinchem/36.11.1871 Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, Proc Natl Acad Sci USA, 76, 4350, 10.1073/pnas.76.9.4350 Carlsson, 1991, Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid, Clin Chim Acta, 196, 167, 10.1016/0009-8981(91)90070-S Pirttilä, 1994, Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer’s disease, vascular dementia and controls, J Neurol Sci, 127, 90, 10.1016/0022-510X(94)90140-6 Kim, 1988, Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide, Neurosci Res Commun, 2, 121 Mehta, 1998, Increased plasma amyloid B protein 1-42 levels in Down Syndrome, Neurosci Lett, 241, 13, 10.1016/S0304-3940(97)00966-X Garton, 1991, Age-related changes in cerebrospinal fluid protein concentrations, J Neurolog Sci, 104, 74, 10.1016/0022-510X(91)90218-V Kass, 1995, Bayes factors, J Amer Statistical Assoc, 90, 773, 10.2307/2291091 Carroll, 1995, An age-related correlation between levels of β-amyloid precursor protein and β-amyloid in human cerebrospinal fluid, Biochem Biophys Res Comm, 210, 345, 10.1006/bbrc.1995.1667 Southwick, 1996, Assessment of amyloid β protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer’s disease, J Neurochem, 66, 259, 10.1046/j.1471-4159.1996.66010259.x Fukumoto, 1996, Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer’s disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques, Am J Pathol, 148, 259 Uchihara, 1996, Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid β protein deposits, Acta Neuropathol, 92, 180, 10.1007/s004010050506 Shirahama, 1982, Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion, Am J Pathol, 107, 41 Ida, 1996, Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay, J Biol Chem, 271, 22908, 10.1074/jbc.271.37.22908 Rissøen, 1988, Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer’s disease, Acta Neurol, 78, 455, 10.1111/j.1600-0404.1988.tb03687.x Herbert, 1986, Transthyretin, Neurol, 36, 900, 10.1212/WNL.36.7.900 Lefranc, 1996, Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer’s disease, Neurosci Lett, 212, 91, 10.1016/0304-3940(96)12774-9 Vigo-Pelfrey, 1994, Characterization of β-amyloid peptides from normal cerebral spinal fluid, J Neurochem, 61, 1965, 10.1111/j.1471-4159.1993.tb09841.x Giannakopoulous, 1996, Early-onset dementias, Acta Neuropathol, 91, 451, 10.1007/s004010050452